logo
Many UTI hospital admissions could be prevented, according to experts

Many UTI hospital admissions could be prevented, according to experts

Rhyl Journal15-07-2025
It comes as new data suggests UTIs cost NHS hospitals in England an estimated £604 million in 2023/24.
Admissions increased by 9% during the year compared with the previous 12 months, according to the UK Health Security Agency (UKHSA).
UTIs can affect the bladder, urethra or kidneys, and can include symptoms such as pain while peeing, blood in the pee, and pain in the tummy or back.
The infections are usually caused by bacteria from poo entering the urinary tract.
UKHSA analysis of the Hospital Episode Statistics (HES) database found there were 189,759 hospital admissions relating to UTIs in England in 2023/24.
This resulted in 1.2 million NHS bed days, averaging six bed days per infection.
However, a third of UTI patients were in hospital for less than a day, meaning other treatment options could be considered, according to the UKHSA.
Dr Colin Brown, deputy director at UKHSA responsible for antibiotic resistance, said: 'Urinary tract infections are a major cause of hospitalisations in this country, but many could be prevented.'
The figures also show hospital admissions for UTIs increased up by 9% in 2023/24 compared with the previous year.
However, levels are still below those seen before the Covid-19 pandemic.
More than half of all UTI admissions (52.7%) included in the data were patients aged over 70, and more than six in 10 (61.8%) were women.
Women were nearly five times more likely to need hospital treatment for a UTI in people under the age of 50.
To avoid catching a UTI, experts advise people to drink enough fluid regularly, avoid holding in pee, wash daily, keep the genital areas clean and dry and wipe from front to back when on the toilet to avoid bacteria spreading.
Dr Brown said: 'We know that the most serious consequences that come from UTIs are more common in people over the age of 50 so we are reminding this group in particular to be aware of the ways they can help reduce their risk of getting poorly.
'Drinking enough fluids is so important, as well as avoiding holding onto pee. If you have frequent UTIs, talk to your healthcare provider about treatments that may help prevent further infections.
'If you have a UTI and your symptoms get worse, please call your GP or 111, or go to your nearest A&E, to seek assistance as UTIs can develop into more serious, life-threatening infections.'
Dr Brown also stressed that preventing UTIs is important to tackle antibiotic resistance, as they are often treated with antibiotics.
'Reducing the number of UTI infections means bacteria has less chance to develop this resistance, helping keep antibiotics working for longer,' he said.
Professor Matt Inada-Kim, national clinical director for infections management and antimicrobial resistance at NHS England, said: 'Urinary tract infections are an increasingly common reason for becoming ill at home and in hospitals.
'They are more serious in older patients and, in particular, those with catheters but they can occur at any age and are not often related to poor hygiene.
'Antimicrobial resistance continues to grow and it is vital that we do everything we can to manage urinary infections through prevention, education and providing easy access to healthcare, including diagnostic tests and appropriate treatment.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Warning fat jab supplies could run out as demand surges with 1 in 5 people trying to buy them last year
Warning fat jab supplies could run out as demand surges with 1 in 5 people trying to buy them last year

The Sun

time7 minutes ago

  • The Sun

Warning fat jab supplies could run out as demand surges with 1 in 5 people trying to buy them last year

FAT jab supplies could run out — with one in five people ­trying to buy them last year. Pharmacists warn that ballooning demand 'goes far beyond what is clinically deliverable'. Millions of Brits are thought to be using fat-busting jabs such as Wegovy, Mounjaro and Ozempic. A poll for the National Pharmacy Association found one in five people, 21 per cent, attempted to buy a fat jab from a pharmacy in the past year. The figure shoots up to 35 per cent among 25 to 34-year-olds. NPA chairman Olivier Picard said: 'It's clear from this polling that many more people are interested in getting weight-loss jabs than would actually be suitable for treatment. ' Weight-loss jabs are one of the biggest drug innovations this century but we want to make sure supplies are carefully managed so that those in most need can benefit. 'We're also urging the Government to bring forward plans to include pharmacies in the roll-out of their NHS weight management programme.' The NHS has increased its roll-out of fat jabs by offering Mounjaro through GP practices, but only 220,000 people are likely to get it by 2028. It could take 12 years to reach everyone who is eligible, so millions are expected to buy them privately. But experts fear such strict access will drive patients to dodgy online sellers who put their health at risk. The poll also found 41 per cent said they would get the jabs on the NHS if they could, even if they were not obese. Watch Ellen's weight loss journey on fat jabs Rules on online prescribing have been tightened to prevent people pretending to be heavier than they are to quality. The injections cause the body to burn fat by turning off hunger signals and stopping you eating. Prescriptions in England for Ozempic, Mounjaro and Wegovy rocketed from 1.4million in 2023-24 to 2.7million last year.

Pharmacies warn of unsustainable demand for weight loss medication
Pharmacies warn of unsustainable demand for weight loss medication

Glasgow Times

time12 minutes ago

  • Glasgow Times

Pharmacies warn of unsustainable demand for weight loss medication

Many more patients are interested in using weight loss medication than are actually suitable for treatment, according to the National Pharmacy Association (NPA), which represents more than 6,000 independent community pharmacies. Some 21% of people who were interviewed in a NPA-commissioned poll agreed they had attempted to access weight loss treatments in the last year, either online or in person at a pharmacy, rising to 35% of 16 to 34-year-olds. This is compared to only 7% of those over 55. There were also 41% who agreed they would opt for weight loss treatments on the NHS if they were made available to them. This figure rose to 64% among 25 to 34-year-olds, despite many of these patients being unlikely to be clinically eligible. The NPA says the poll, in which 2,002 people were interviewed, reflects an increasing demand for private and NHS weight loss services. NPA chairman Olivier Picard said: 'Weight loss jabs are one of the biggest drug innovations this century, but growing demand for weight loss treatment highlights the need to make sure this is appropriate for those who want it. 'It's clear from this polling that many more people are interested in getting weight loss jabs than would actually be suitable for treatment. 'We want to make sure supplies are carefully managed so that those in most clinical need can benefit from weight loss medication.' Spiralling demand, fuelled partly by social media, could see people being tempted to resort to unregulated online suppliers instead of regulated pharmacies staffed by medical professionals, they fear. Online suppliers may not be offering weight loss jabs alongside a structured programme aimed at helping them change their behaviour. Wegovy and Mounjaro are among a number of drugs that are recommended to help tackle obesity on the NHS. Mounjaro and Wegovy are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in patients with a BMI of over 30 or between 27 and 30 but with a weight-related co-morbidity. This occurs when an individual who has obesity develops another medical condition due to their weight. The NHS currently rolls out Mounjaro to patients with a BMI of over 40 and at least four co-morbidities, the NPA says. The NPA is calling for new regulations to protect patients buying weight loss medication online, so there is a full two-way consultation and all relevant historical medical records are reviewed before the treatment is prescribed. They are waiting for more details about the role pharmacies could play in the rollout of the NHS weight management programme. At least 85% of weight loss medication prescriptions were made by pharmacies in April this year, the NPA estimates. Mr Picard said: 'Pharmacists are experts in medication and many have extensive experience delivering weight loss injections as part of a package of care, including lifestyle advice. 'Pharmacies are well placed to help roll this treatment out on the NHS, and help people make the best use of these powerful medicines.'

Pharmacy warning of unsustainable demand for weight loss medication
Pharmacy warning of unsustainable demand for weight loss medication

The Independent

time37 minutes ago

  • The Independent

Pharmacy warning of unsustainable demand for weight loss medication

The National Pharmacy Association (NPA) has issued a warning that the burgeoning demand for weight loss injections may be unsustainable, citing a significant mismatch between public interest and clinical suitability for the treatments. The NPA, which represents over 6,000 independent community pharmacies, highlighted this concern. A poll commissioned by the association revealed that 21 per cent of respondents had attempted to access weight loss treatments in the past year, either online or directly from a pharmacy. This figure surged to 35 per cent among 16 to 34-year-olds, contrasting sharply with just seven per cent of those over 55. There were also 41% who agreed they would opt for weight loss treatments on the NHS if they were made available to them. This figure rose to 64% among 25 to 34-year-olds, despite many of these patients being unlikely to be clinically eligible. The NPA says the poll, in which 2,002 people were interviewed, reflects an increasing demand for private and NHS weight loss services. NPA chairman Olivier Picard said: 'Weight loss jabs are one of the biggest drug innovations this century, but growing demand for weight loss treatment highlights the need to make sure this is appropriate for those who want it. 'It's clear from this polling that many more people are interested in getting weight loss jabs than would actually be suitable for treatment. 'We want to make sure supplies are carefully managed so that those in most clinical need can benefit from weight loss medication.' Spiralling demand, fuelled partly by social media, could see people being tempted to resort to unregulated online suppliers instead of regulated pharmacies staffed by medical professionals, they fear. Online suppliers may not be offering weight loss jabs alongside a structured programme aimed at helping them change their behaviour. Wegovy and Mounjaro are among a number of drugs that are recommended to help tackle obesity on the NHS. Mounjaro and Wegovy are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in patients with a BMI of over 30 or between 27 and 30 but with a weight-related co-morbidity. This occurs when an individual who has obesity develops another medical condition due to their weight. The NHS currently rolls out Mounjaro to patients with a BMI of over 40 and at least four co-morbidities, the NPA says. The NPA is calling for new regulations to protect patients buying weight loss medication online, so there is a full two-way consultation and all relevant historical medical records are reviewed before the treatment is prescribed. They are waiting for more details about the role pharmacies could play in the rollout of the NHS weight management programme. At least 85% of weight loss medication prescriptions were made by pharmacies in April this year, the NPA estimates. Mr Picard said: 'Pharmacists are experts in medication and many have extensive experience delivering weight loss injections as part of a package of care, including lifestyle advice. 'Pharmacies are well placed to help roll this treatment out on the NHS, and help people make the best use of these powerful medicines.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store